Papers: 13 Aug 2012 - 20 Aug 2012
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
Heligmosmoides polygyrus: EAE remission is correlated with different systemic cytokine profiles provoked by L4 and adult nematodes.
Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.
The Ifng Gene Is Essential for Vdr Gene Expression and Vitamin D3-Mediated Reduction of the Pathogenic T Cell Burden in the Central Nervous System in Experimental Autoimmune Encephalomyelitis, a Multiple Sclerosis Model.
Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
Persons with multiple sclerosis show altered joint kinetics during walking after participating in elliptical exercise.
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
IFN-γ-induced apoptosis of human embryonic stem cell derived oligodendrocyte progenitor cells is restricted by CXCR2 signaling.
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review.
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two.
Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.
The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data.
Correction: Correlation of Diffusion and Metabolic Alterations in Different Clinical Forms of Multiple Sclerosis.
Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells.
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography.
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis.